LAST night's federal budget included details of a much-anticipated new strategic agreement between Medicines Australia and the government, "to support ongoing access to the latest innovative medicines for patients, significant savings to taxpayers and provide much needed stability for the innovative medicines industry".
MA chairman Wes Cook said the agreement "upholds the key principles sought by Medicines Australia, such as the need for policy predictability and certainty for industry; acknowledgement that the industry is currently delivering savings through recent reforms and that the additional savings generated for taxpayers will be reinvested into new medicines on the PBS."
The above article was sent to subscribers in Pharmacy Daily's issue from 10 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 May 17